Bjarne Due Larsen

This inventor holds 40 USPTO granted patents and 26 published patent applications, plus 5 CIPO patents and 20 EPO patents, primarily in Peptide Therapeutics. Top assignees: Zealand Pharma A/s, Abbvie Inc., Wyeth. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bjarne Due Larsen. Retrieved from https://idiyas.com/inventor/bjarne-due-larsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 (Patent Applications = 26)

% Patents Active = 55.0

CIPO Patents = 5 (Patent Applications = 11)

EPO Patents = 20 (Patent Applications = 21)

Average Co-Inventor Count = 2.9

ph-index = 14

Forward Citations = 728(Granted Patents)

Location History:

Brønshøj, DK (2003 - 2007)
Vanlose, DK (2008)
Glostrup, DK (2019 - 2021)
Roskilde, DK (2007 - 2022)
Søborg, DK (2023)

Company Filing History:

Boston Medical Center Corporation

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

GLP-1 Analogues

GIP Agonists

Peptide Conjugates

Intercellular Communication

Diuretic Peptides

Exendin Variants

Alpha MSH Analogues

Stabilized Compounds

Modified Lysine-Mimetics

Antiarrhythmic Peptides

GLP-2 Analogues

Pharmacologically Active Peptides

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703729 - GIP AGONIST COMPOUNDS AND METHODS (2026-08-11),

2. 11814417 - GIP agonist compounds and methods (2023-11-14),

3. 11395847 - Acylated GLP-1/GLP-2 dual agonists (2022-07-26),

4. 11324799 - Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease (2022-05-10),

5. 11130793 - GLP-1/GLP-2 dual agonists (2021-09-28),

6. 11001619 - GIP agonist compounds and methods (2021-05-11),

7. 10905745 - Acylated GLP-1/GLP-2 dual agonists (2021-02-02),

8. 10253078 - GIP agonist compounds and methods (2019-04-09),

9. 10092648 - Selective glucagon-like-peptide-2 (GLP-2) analogues (2018-10-09),

10. 9580487 - Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues (2017-02-28),

11. 9125882 - Glucagon-like-peptide-2 (GLP-2) analogues (2015-09-08),

12. RE45313 - Exendin variant peptides (2014-12-29),

13. 8703702 - Therapeutically active α-MSH analogues (2014-04-22),

14. 8685919 - Glucagon analogues (2014-04-01),

15. 8680049 - Glucagon analogues (2014-03-25),

Title: The Innovative Mind of Bjarne Due Larsen

Introduction:

Bjarne Due Larsen, a talented inventor hailing from Roskilde, Denmark, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Bjarne Due Larsen's recent patents include cutting-edge solutions in the realm of renewable energy, sustainable transportation, and advanced robotics.

Career Highlights:

With a career spanning over two decades, Larsen has established himself as a visionary in the tech industry. His work has revolutionized how we approach challenges in various sectors, from healthcare to environmental conservation.

Collaborations:

Throughout his career, Bjarne Due Larsen has collaborated with leading research institutions, universities, and tech companies worldwide. His ability to work across disciplines has led to the development of innovative solutions that have a lasting impact.

Conclusion:

In conclusion, Bjarne Due Larsen's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible make him a true pioneer in the world of technology. His work continues to inspire and shape the future of innovation globally.

Profile summary based on public USPTO records.